Reduction of OTUB1 decreased NS2-mediated vRNP nuclear export. by Yu-Jyun Li (18700176)

Knockdown of endogenous Cdk-5 decreases T-type Ca2+ channel functional expression. by Aida Calderón-Rivera (701054)

Decreased 5-hmC expression was associated with <i>TET2</i> downregulation. by Xuejiao Shi (1684186)

Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D. by Eiko Kitamura (349087)

“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Cytochalasin D decreases ENaC activity when the channel coexpressed with RhoA. by Alexey V. Karpushev (367701)

Decreased ocular size lesions in dogs treated with oxfendazole. by Vito Colella (725841)

“…<p>Decreased ocular size lesions in dogs n. 5 (A) and n. 9 (B) at 0 (D0), 90 (D90) and 180 (D180) days post enrolment.…”

DualAG decreased TG synthesis in DIO mice. by Vijay R. More (4532392)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC₅₀ = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

The CaM-binding mutation in PC1 decreases macroscopic current through PC1/PC2 channels. by Nicholas Doerr (2446855)

Decreasing cell adhesion decreases [Ca²⁺]_i oscillation frequency. by Charles Godbout (540424)

PPP2R5C HepKD in <i>db/db</i> mouse liver improves insulin sensitivity, decreases hyperglycemia, but worsens the dyslipidemia. by Yong-Sheng Cheng (803758)

“…<p><b>(A)</b> Hyperglycemia in <i>db/db</i> mice is decreased upon hypatocyte-specific PPP2R5C knockdown with adeno-associated virus. …”

Pharmacological inhibition of EGFR decreases reduces a subset of the inflammatory response at day 2 post-infection. by Marc Swidergall (185453)

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

GXMGal effect on different subsets of Treg cells. by Eva Pericolini (290617)

MSCs decrease oligodendrocyte death. by Justin D. Glenn (800439)

Decrease of ECT2 phosphorylation at T359 residue in DLC1 overexpressing cells. by Yesim Gökmen-Polar (437000)

“…<p><b>A.</b> Significant decrease in two phosphopeptides (ANTPELK) and (ANTPELKK, with one missed cleavage) in DLC1-FL overexpressing cells compared to control vector cells (FDR-corrected <i>p</i>-value < 0.1). …”

Inhibition of G9a decreases the tumorigenicity of neuroblastoma cells. by Xiao-Xue Ke (626989)